Frequency of Driver Genes (EGFR, KRAS, BRAF, ALK, RET and ROS1) Alterations in Brazilian Patients with Lung Adenocarcinoma

被引：2
|
作者：
Campanha Novaes, L. [1 ]
Cavagna, R. [1 ]
De Paula, F. [2 ]
De Marchi, P. [3 ]
Zanon Da Silva, M. [2 ]
Evangelista, A. [1 ]
Sussuchi Da Silva, L. [1 ]
Albino Da Silva, E. [4 ]
Leal, L. [1 ]
Reis, R. [1 ]
机构：
[1] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil
[2] Barretos Canc Hosp, Dept Mol Diag, Barretos, Brazil
[3] Barretos Canc Hosp, Clin Oncol, Barretos, Brazil
[4] Barretos Canc Hosp, Pathol, Barretos, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
driver genes; Brazilian patients; lung adenocarcinoma;
D O I：
10.1016/j.jtho.2019.08.1454
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03-07
引用
收藏
页码：S685 / S685
页数：1
相关论文
共 50 条
  • [21] EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancer
    Dong, Yu
    Ren, Weihong
    Qi, Jun
    Jin, Bo
    Li, Ying
    Tao, Huiqing
    Xu, Ren
    Li, Yanqing
    Zhang, Qinxian
    Han, Baohui
    ONCOLOGY LETTERS, 2016, 11 (04) : 2371 - 2378
  • [22] Detection of ALK, RET, ROS1 Rearrangements by NanoString in Brazilian Patients with Non-small Cell Lung Cancer
    Novaes, L.
    de Paula, F.
    Evangelista, A.
    Mattos, L.
    De Marchi, P.
    Silva, C.
    Ferro, L.
    Reis, R. M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 986 - 986
  • [23] Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma
    Lee, Seung Eun
    Lee, Boram
    Hong, Mineui
    Song, Ji-Young
    Jung, Kyungsoo
    Lira, Maruja E.
    Mao, Mao
    Han, Joungho
    Kim, Jhingook
    Choi, Yoon-La
    MODERN PATHOLOGY, 2015, 28 (04) : 468 - 479
  • [24] Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach
    Yoon, Hyun Jung
    Sohn, Insuk
    Cho, Jong Ho
    Lee, Ho Yun
    Kim, Jae-Hun
    Choi, Yoon-La
    Kim, Hyeseung
    Lee, Genehee
    Lee, Kyung Soo
    Kim, Jhingook
    MEDICINE, 2015, 94 (41)
  • [25] ALK and ROS 1 concurrent with EGFR mutation in patients with lung adenocarcinoma
    Mao, Yanjiao
    Wu, Shixiu
    ONCOTARGETS AND THERAPY, 2017, 10 : 3399 - 3404
  • [26] Outcomes of EGFR, ALK, ROS1, BRAF, MET, and RET mutated non-small cell lung cancer with brain metastases (NSCLC BM).
    Li, Xiaoyan
    Shi, Weiwei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 201 - 201
  • [27] Detecting ALK, ROS1 and RET Fusion Genes in Cell Block Samples
    Zhao, Chao
    Li, Xuefei
    Li, Jiayu
    Zhang, Yishi
    Ren, Shengxiang
    Chen, Xiaoxia
    Zhou, Caicun
    TRANSLATIONAL ONCOLOGY, 2014, 7 (03): : 363 - 367
  • [28] The Frequency and Clinical Implication of ALK, ROS1, RET and NTRK1 Gene Rearrangements in Adenosquamous Lung Carcinoma Patients
    Shi, X.
    Wu, S.
    Duan, H.
    Liu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2274 - S2274
  • [29] New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1)
    Russo, Alessandro
    Lopes, Ana Rita
    McCusker, Michael G.
    Garrigues, Sandra Gimenez
    Ricciardi, Giuseppina R.
    Arensmeyer, Katherine E.
    Scilla, Katherine A.
    Mehra, Ranee
    Rolfo, Christian
    CURRENT ONCOLOGY REPORTS, 2020, 22 (05)
  • [30] Precision Treatment of Advanced Lung Adenocarcinoma With Coexisting EGFR, ALK, and ROS1 Mutations: A Case Report
    Zhang, Yaping
    Wang, Hui
    Wang, Xiaoyan
    Li, Shuai
    Fang, Hongming
    CLINICAL LUNG CANCER, 2021, 22 (05) : E699 - E702
12345